- 专利标题： END-TO-END CELL THERAPY AUTOMATION
-
申请号： US17751999申请日： 2022-05-24
-
公开(公告)号： US20220282213A1公开(公告)日： 2022-09-08
- 发明人: Yaling SHI , Erika MCAFEE , Samatha BANDAPALLE , Ann SIEHOFF , Timo GLEISSNER , Joseph O'CONNOR , Eytan ABRAHAM , Kelly PURPURA , Nuala TRAINOR , Timothy SMITH
- 申请人： LONZA WALKERSVILLE, INC. , LONZA COLOGNE GMBH , OCTANE BIOTECH INC.
- 申请人地址： US MD Walkersville; DE Cologne; CA Kingston
- 专利权人： LONZA WALKERSVILLE, INC.,LONZA COLOGNE GMBH,OCTANE BIOTECH INC.
- 当前专利权人： LONZA WALKERSVILLE, INC.,LONZA COLOGNE GMBH,OCTANE BIOTECH INC.
- 当前专利权人地址： US MD Walkersville; DE Cologne; CA Kingston
- 主分类号： C12N5/0783
- IPC分类号： C12N5/0783 ; C12M3/00 ; C12M1/00 ; C12M1/34 ; C07K14/725 ; C07K14/705 ; C12N5/00 ; C12N5/16 ; C12N15/86
摘要：
The present disclosure provides an automated method of producing genetically modified immune cells, including chimeric antigen receptor T (CAR T) cells, utilizing a fully-enclosed cell engineering system.
公开/授权文献
- US11827902B2 End-to-end cell therapy automation 公开/授权日：2023-11-28
信息查询
